1500005I dynport vaccine company, LLC; to FY.2019.A1.0118--05 base task order funding; biod can 8470038 $117,283
Ended Awarded Last action
- Contract number
- 75N93019F00125
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $99,979
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $99,978.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$17,304 | |
| Original award | $117,283 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Dynport Vaccine Company LLC on December 14, 2018, under the Therapeutics Against Infectious Diseases Phase 1 IDIQ, with a ceiling value of $99,978.65 for Phase 1 clinical trial unit operations.
Place of performance is Frederick, Maryland. The order was funded under Cost Plus Fixed Fee pricing with ultimate completion on December 14, 2019. The work supports a Phase 1 clinical trial unit for therapeutics against infectious diseases under Task Area A.
Quick answers
Who was awarded contract 75N93019F00125?
75N93019F00125 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 14, 2018.
How much is contract 75N93019F00125 worth?
The government has obligated $99,979 on 75N93019F00125.
Is contract 75N93019F00125 an order under another contract?
Yes. 75N93019F00125 is a delivery order under HHSN272201500005I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract 75N93019F00125 competed?
The extent of competition for 75N93019F00125 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award